Have a personal or library account? Click to login
SARS-CoV2 Infection in a Multiple Sclerosis Patient Treated with Natalizumab – A Case Presentation Cover

SARS-CoV2 Infection in a Multiple Sclerosis Patient Treated with Natalizumab – A Case Presentation

Acta Marisiensis - Seria Medica
Volume 66 (2020): Issue 3 (September 2020)
By: Georgiana Șerban and  Rodica Bălașa  
Open Access
|Sep 2020
DOI: https://doi.org/10.2478/amma-2020-0022 | Journal eISSN: 2668-7763 | Journal ISSN: 2668-7755
Journal RSS Feed
Language: English
Page range: 110 - 112
Submitted on: Aug 20, 2020
|
Accepted on: Sep 1, 2020
|
Published on: Sep 29, 2020
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
multiple sclerosis,
Natalizumab,
SARS-CoV2 infection,
COVID-19 outbreak
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2020 Georgiana Șerban, Rodica Bălașa, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 66 (2020): Issue 3 (September 2020)Next article